| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |